Free tool
Oncology stocks
We cover 6 companies grouped under the Oncology theme. The median market value in the group is $67.36M. Across the group, the median move over the past trading day is +0.61%. Price change over the past year runs from −63.3% to +179.9% across the middle 80 percent of the group, with a median of −37.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
6 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% | Sep 29, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | $88.75M | Micro cap | −47.94% | Sep 28, 2026 |
| 0J4V.L | Heron Therapeutics, Inc. | $82.85M | Micro cap | −78.12% | Nov 3, 2026 |
| 0RAD.L | OSE Immunotherapeutics SA | $51.87M | Micro cap | −48.50% | Sep 28, 2026 |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% | Nov 25, 2026 |
| 0GP7.L | Medivir AB (publ) | $5.78M | Micro cap | +1.60% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.